Primer: Astellas Pharma (4503 JP) - Aug 2026
Astellas is navigating a critical transition period, with its blockbuster prostate cancer drug, Xtandi, facing a patent cliff starting in 2027....
120 Views
Primer: Astellas Pharma (4503 JT) - Sep 2025
Astellas is a global pharmaceutical company with a strategic focus on oncology, urology, immunology, nephrology, and neuroscience, driving...
118 Views